330 filings
8-K
AUPH
Aurinia Pharmaceuticals Inc
14 Jun 24
Submission of Matters to a Vote of Security Holders
5:25pm
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 Jun 24
Additional proxy soliciting materials
6:28pm
ARS
2023 FY
AUPH
Aurinia Pharmaceuticals Inc
3 May 24
Annual report to shareholders
4:16pm
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 May 24
Additional proxy soliciting materials
4:11pm
8-K
4nvkywzf uuw6
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
8-K
mhl30
29 Feb 24
Departure of Directors or Certain Officers
4:10pm
8-K
jtkjuoalyl
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
bjvsnhp6i0yk1nqevi8j
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
8-K
e56qxb7
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
8-K
vxvrl
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
1ga77ger7qw48
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
8-K
x9bofp7
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
PX14A6G
y41qxjy h8
6 Jul 23
Letter to shareholders
8:33am